These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8367983)

  • 21. Alcohol and other factors affecting osteoporosis risk in women.
    Sampson HW
    Alcohol Res Health; 2002; 26(4):292-8. PubMed ID: 12875040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
    Black DM; Bilezikian JP; Ensrud KE; Greenspan SL; Palermo L; Hue T; Lang TF; McGowan JA; Rosen CJ;
    N Engl J Med; 2005 Aug; 353(6):555-65. PubMed ID: 16093464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily and cyclic parathyroid hormone in women receiving alendronate.
    Cosman F; Nieves J; Zion M; Woelfert L; Luckey M; Lindsay R
    N Engl J Med; 2005 Aug; 353(6):566-75. PubMed ID: 16093465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of bone remodeling by active vitamin D: its role in the treatment of osteoporosis.
    Ikeda K; Ogata E
    Mech Ageing Dev; 2000 Jul; 116(2-3):103-11. PubMed ID: 10996010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
    Black DM; Greenspan SL; Ensrud KE; Palermo L; McGowan JA; Lang TF; Garnero P; Bouxsein ML; Bilezikian JP; Rosen CJ;
    N Engl J Med; 2003 Sep; 349(13):1207-15. PubMed ID: 14500804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacology of bone.
    Raisz LG
    Ration Drug Ther; 1971 Jun; 5(6):1-7. PubMed ID: 5565260
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of osteoporosis with fluoride.
    Riggs BL; Jowsey J
    Semin Drug Treat; 1972; 2(1):27-33. PubMed ID: 5048562
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of alcohol on bone mineral density in men].
    Medraś M; Jankowska EA
    Przegl Lek; 2000; 57(12):743-6. PubMed ID: 11398600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrine disease: progress in diagnosis and treatment. Topics: II. Progress in treatment; 5. Role of parathyroid hormone in bone metabolism and its clinical implication].
    Takeuchi Y
    Nihon Naika Gakkai Zasshi; 2012 Apr; 101(4):1007-14. PubMed ID: 22730729
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of chronic alcohol ingestion on bone mineral density in males without liver cirrhosis.
    Kim MJ; Shim MS; Kim MK; Lee Y; Shin YG; Chung CH; Kwon SO
    Korean J Intern Med; 2003 Sep; 18(3):174-80. PubMed ID: 14619387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone and mineral metabolism and chronic alcohol abuse.
    Lalor BC; France MW; Powell D; Adams PH; Counihan TB
    Q J Med; 1986 May; 59(229):497-511. PubMed ID: 3763813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deranged bone mineral metabolism in chronic alcoholism.
    Feitelberg S; Epstein S; Ismail F; D'Amanda C
    Metabolism; 1987 Apr; 36(4):322-6. PubMed ID: 3494181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine regulation of bone turnover in men.
    Meier C; Liu PY; Handelsman DJ; Seibel MJ
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):603-16. PubMed ID: 16343093
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth hormone, insulin-like growth factors and bone remodelling.
    Eriksen EF; Kassem M; Langdahl B
    Eur J Clin Invest; 1996 Jul; 26(7):525-34. PubMed ID: 8864413
    [No Abstract]   [Full Text] [Related]  

  • 36. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone and periosteal bone expansion.
    Parfitt AM
    J Bone Miner Res; 2002 Oct; 17(10):1741-3. PubMed ID: 12369776
    [No Abstract]   [Full Text] [Related]  

  • 38. Coming to grips with bone loss.
    Marx J
    Science; 2004 Sep; 305(5689):1420-2. PubMed ID: 15353792
    [No Abstract]   [Full Text] [Related]  

  • 39. [Alcoholic osteopathy].
    Sarli M; Plotkin H; Zanchetta JR
    Medicina (B Aires); 1994; 54(4):363-70. PubMed ID: 7715435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of anticonvulsant drug-induced bone disease.
    Drezner MK
    Epilepsy Behav; 2004 Feb; 5 Suppl 2():S41-7. PubMed ID: 15123011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.